2021 Cardiovascular Competitive Grant Program – Request for Proposals

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: Inquire with your unit

Memorial Deadline: No RGCS review required for the Request for Proposals

External Deadline: Friday 12th, March 2021


Description

2021 Global ANGPTL3 ASPIR – Please note the deadline for submission is 23:59 Eastern Time (New York, GMT -5).

ASPIRE – Advancing Science and Patient care through Innovative Research and Education

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that
provides detail regarding a specific area of interest, sets timelines for review and approval, and uses
an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an
application addressing the specific gaps in research, practice or care as outlined in the specific RFP.

For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and
ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the
independent initiative supported by the grant, including compliance with any regulatory requirements.
Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or
monitoring of the research program.

Additional information can be found here.


Funding Sources

Pfizer Inc



This opportunity was posted by: RGCS

Last modified: February 1, 2021